article thumbnail

The International Council for Harmonization (ICH) Q10: A Model for a Robust Pharmaceutical Quality Management System

Open Medscience

ICH Q10 is a global model for managing pharmaceutical quality, ensuring compliance, continuous improvement, and risk manage The post The International Council for Harmonization (ICH) Q10: A Model for a Robust Pharmaceutical Quality Management System appeared first on Open MedScience.

article thumbnail

Big Data and Pharma

MRI Network

Big data has become a pillar in modern pharmaceutical practices. Pharmaceutical companies have also leveraged big data in third-party collaborations, resulting in more efficient product deployment and customer experiences. Industry experts predict the pharmaceutical analytical testing market could total an estimated USD 8.98

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

TeleDaaS Launches as Premier Provider of Dosimetry as a Service for Clinical Research Organizations

Imaging Technology

TeleDaaS specializes in delivering clinical-grade, precision-based dosimetry analysis and treatment plans to clinical research organizations (CROs) and pharmaceutical manufacturers. TeleDaaS licenses a cloud-based technology platform from Mirada Medical.

Clinic 78
article thumbnail

Impact of Robotics Across Pharma

MRI Network

Industry research forecasts the global pharmaceutical robots market size expanding at a compound annual growth rate (CAGR) of 8.7% Recent industry figures show an 11.35% month-over-month (MoM) spike in active robotics-related job postings in the global pharmaceuticals sector. from 2023 to 2030.

article thumbnail

The RAMPP Trial: Randomised Ambulatory Management of Primary Pneumothorax

REBEL EM

Previous studies regarding ambulatory management included randomized trials that lacked adequate power, and recently, a 2013 systematic review that, although showed promise in the ambulatory approach, had poor data quality with a high risk of bias. Pharmaceutical industry sponsorship and research outcome and quality: systematic review.